Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Archives of Pathology & Laboratory Medicine
|
January 3, 2012
Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma
Suzanne Kamel-Reid, Tong Zhang, Diane L Persons, et al.
Cancer Genetics and Cytogenetics
|
February 27, 2007
Biclonal post-transplant B-cell lymphoma: report of a case with two distinct cell populations, XX,t(14;18) and XY,t(11;14)
Katie L Dennis, Steven L Wallentine, Peter J Vanveldhuizen, et al.
Archives of Pathology & Laboratory Medicine
|
January 3, 2012
Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease
Lawrence J Jennings, Frederick A Smith, Kevin C Halling, et al.
Cancer Genetics and Cytogenetics
|
June 19, 2007
Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study
Sandra R Wolman, Bryan Goldman, Marilyn L Slovak, et al.
Cancer Detection and Prevention
|
September 25, 2002
Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization
Marilyn L Slovak, Feiyu Zhang, Lucene Tcheurekdjian, et al.
Archives of Pathology & Laboratory Medicine
|
May 8, 2018
Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests
Katherine B Geiersbach, Julia A Bridge, Michelle Dolan, et al.
Archives of Pathology & Laboratory Medicine
|
April 28, 2009
Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines
Gail H Vance, Todd S Barry, Kenneth J Bloom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431)
Stephen R Moore, Diane L Persons, Jeffrey A Sosman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 23, 2003
Problems with ISCN FISH Nomenclature make it not practical for use in clinical test reports or cytogenetic databases [corrected]
James T Mascarello, Linda D Cooley, Keri Davison, et al.
The Journal of Urology
|
June 7, 2006
Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria
Michael F Sarosdy, Paul R Kahn, Mark D Ziffer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Archives of Pathology & Laboratory Medicine
|
January 3, 2012
Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma
Suzanne Kamel-Reid, Tong Zhang, Diane L Persons, et al.
Cancer Genetics and Cytogenetics
|
February 27, 2007
Biclonal post-transplant B-cell lymphoma: report of a case with two distinct cell populations, XX,t(14;18) and XY,t(11;14)
Katie L Dennis, Steven L Wallentine, Peter J Vanveldhuizen, et al.
Archives of Pathology & Laboratory Medicine
|
January 3, 2012
Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease
Lawrence J Jennings, Frederick A Smith, Kevin C Halling, et al.
Cancer Genetics and Cytogenetics
|
June 19, 2007
Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study
Sandra R Wolman, Bryan Goldman, Marilyn L Slovak, et al.
Cancer Detection and Prevention
|
September 25, 2002
Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization
Marilyn L Slovak, Feiyu Zhang, Lucene Tcheurekdjian, et al.
Archives of Pathology & Laboratory Medicine
|
May 8, 2018
Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests
Katherine B Geiersbach, Julia A Bridge, Michelle Dolan, et al.
Archives of Pathology & Laboratory Medicine
|
April 28, 2009
Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines
Gail H Vance, Todd S Barry, Kenneth J Bloom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431)
Stephen R Moore, Diane L Persons, Jeffrey A Sosman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 23, 2003
Problems with ISCN FISH Nomenclature make it not practical for use in clinical test reports or cytogenetic databases [corrected]
James T Mascarello, Linda D Cooley, Keri Davison, et al.
The Journal of Urology
|
June 7, 2006
Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria
Michael F Sarosdy, Paul R Kahn, Mark D Ziffer, et al.
Page
of 3